Cargando…

HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models

SIMPLE SUMMARY: Mammary tumors are common in cats, presenting an aggressive behavior with high tumor recurrence. Therefore, new and efficient therapeutic protocols are urgent. Monoclonal antibodies (mAbs; ADC) are widely used in human breast cancer therapy, inhibiting the HER2 dimerization and leadi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gameiro, Andreia, Nascimento, Catarina, Correia, Jorge, Ferreira, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122524/ https://www.ncbi.nlm.nih.gov/pubmed/33919468 http://dx.doi.org/10.3390/cancers13092007

Ejemplares similares

VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes
por: Gameiro, Andreia, et al.
Publicado: (2021)

Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma
por: Gameiro, Andreia, et al.
Publicado: (2021)

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications
por: Nascimento, Catarina, et al.
Publicado: (2022)

Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
por: Gameiro, Andreia, et al.
Publicado: (2021)

Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes
por: Nascimento, Catarina, et al.
Publicado: (2020)

HER2-positive feline mammary carcinoma
por: Marques, Cláudia, et al.
Publicado: (2016)

Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma
por: Gameiro, Andreia, et al.
Publicado: (2021)

CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors
por: Marques, Cláudia S., et al.
Publicado: (2018)

Histone Deacetylase Inhibitors and Microtubule Inhibitors Induce Apoptosis in Feline Luminal Mammary Carcinoma Cells
por: Almeida, Filipe, et al.
Publicado: (2021)

TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma
por: Valente, Sofia, et al.
Publicado: (2023)

fHER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions
por: Soares, Maria, et al.
Publicado: (2022)

Gene expression association study in feline mammary carcinomas
por: Ferreira, Daniela, et al.
Publicado: (2019)

Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status
por: Soares, Maria, et al.
Publicado: (2016)

Anaplastic Mammary Carcinoma in Cat
por: Soares, Maria, et al.
Publicado: (2021)

Serum SDF-1 levels are a reliable diagnostic marker of feline mammary carcinoma, discriminating HER2-overexpressing tumors from other subtypes
por: Marques, Cláudia S., et al.
Publicado: (2017)

Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma
por: Urbano, Ana Catarina, et al.
Publicado: (2020)

Assessment of ERBB2 and TOP2α gene status and expression profile in feline mammary tumors: findings and guidelines
por: Ferreira, Daniela, et al.
Publicado: (2019)

CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017)

P-cadherin expression in feline mammary tissues
por: Figueira, A Catarina, et al.
Publicado: (2010)

P-Cadherin Expression in Feline Mammary Tissues
por: Figueira, Ana Catarina, et al.
Publicado: (2012)

Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
por: Figueira, Ana Catarina, et al.
Publicado: (2014)

Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
por: Ordás, Javier, et al.
Publicado: (2007)

Lymphatic vessels assessment in feline mammary tumours
por: Sarli, Giuseppe, et al.
Publicado: (2007)

Conservative treatments for feline fibroadenomatous changes of the mammary gland
por: Marino, Gabriele, et al.
Publicado: (2021)

Characterization of a continuous feline mammary epithelial cell line susceptible to feline epitheliotropic viruses
por: Pesavento, Patricia, et al.
Publicado: (2009)

Immunohistochemical Expression of p62 in Feline Mammary Carcinoma and Non-Neoplastic Mammary Tissue
por: Magi, Gian Enrico, et al.
Publicado: (2022)

Antiproliferative Effects of Oxytocin and Desmopressin on Canine Mammary Cancer Cells
por: Benavente, Micaela Andrea, et al.
Publicado: (2016)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Significance of sphingosine kinase 1 expression in feline mammary tumors
por: Chang, Yi-Chih, et al.
Publicado: (2019)

Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival
por: Granados-Soler, José Luis, et al.
Publicado: (2020)

Barbiturate- and Thiobarbituarte-Based s-Triazine Hydrazone Derivatives with Promising Antiproliferative Activities
por: Al Rasheed, Hessa, et al.
Publicado: (2020)

Benzimidazole scaffolds as promising antiproliferative agents: a review
por: Tahlan, Sumit, et al.
Publicado: (2019)

Serum Amyloid A Promotes Invasion of Feline Mammary Carcinoma Cells
por: TAMAMOTO, Takashi, et al.
Publicado: (2014)

Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma
por: Rosen, Suzanne, et al.
Publicado: (2020)

Establishment and Characterization of Feline Mammary Tumor Patient-Derived Xenograft Model
por: Chuang, Hsiao-Li, et al.
Publicado: (2021)

Four cases of cell cannibalism in highly malignant feline and canine tumors
por: Ferreira, Fernando Costa, et al.
Publicado: (2015)

Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas
por: Chocteau, Florian, et al.
Publicado: (2019)

A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells
por: Mendanha, Daniel, et al.
Publicado: (2021)

Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
por: Bachawal, Sunitha V, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tfqp665cg5gl0f0aa8adg1a4in